Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.280
+0.030 (2.40%)
At close: Nov 4, 2024, 4:00 PM
1.290
+0.010 (0.78%)
After-hours: Nov 4, 2024, 6:07 PM EST

Protalix BioTherapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for PLX stock has a target of 10, which predicts an increase of 681.25% from the current stock price of 1.28.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $10 $10 $10
Change +681.25% +681.25% +681.25% +681.25%
* Price targets were last updated on Nov 14, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for PLX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '23Jul '23Aug '23Sep '23Oct '23Nov '23
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$10
Strong Buy Reiterates $10 +681.25% Nov 14, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$7$10
Strong Buy Maintains $7$10 +681.25% Oct 31, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$11$7
Strong Buy Maintains $11$7 +446.88% May 3, 2021
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$3$11
Strong Buy Maintains $3$11 +759.38% Jun 8, 2020
Rodman & Renshaw
Rodman & Renshaw
Strong Buy
Reiterates
$40$50
Strong Buy Reiterates $40$50 +3,806.25% Apr 17, 2017
More Analyst Ratings

Financial Forecast

Revenue This Year
54.22M
from 65.49M
Decreased by -17.21%
Revenue Next Year
102.45M
from 54.22M
Increased by 88.94%
EPS This Year
0.02
from 0.09
Decreased by -76.69%
EPS Next Year
0.63
from 0.02
Increased by 3,000.00%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
54.69M62.90M38.35M47.64M65.49M54.22M102.45M168.90M
Revenue Growth
59.73%15.00%-39.03%24.22%37.48%-17.21%88.94%64.86%
EPS
-1.23-0.22-0.62-0.310.090.020.631.14
EPS Growth
------76.69%3,000.00%82.26%
Forward PE
-----63.372.041.12
No. Analysts -----322
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 56.4M 106.5M 175.6M
Avg 54.2M 102.5M 168.9M
Low 52.6M 99.4M 163.9M

Revenue Growth

Revenue Growth 202420252026
High
-13.9%
96.4%
71.4%
Avg
-17.2%
88.9%
64.9%
Low
-19.7%
83.3%
60.0%

EPS Forecast

EPS 202420252026
High 0.02 0.65 1.19
Avg 0.02 0.63 1.14
Low 0.02 0.61 1.11

EPS Growth

EPS Growth 202420252026
High
-75.8%
3,122.8%
89.5%
Avg
-76.7%
3,000.0%
82.3%
Low
-77.4%
2,907.9%
76.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.